Imatinib mesylate (STI-571) given concurrently with nonmyeloablative stem cell transplantation did not compromise engraftment and resulted in cytogenetic remission in a patient with chronic myeloid leukemia in blast crisis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples